deltatrials
Completed PHASE4 NCT00941096

Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination

Efficacy Of The Bimatoprost/Timolol Fixed Combination In Patients Treated With Bimatoprost for Primary Open Angle Glaucoma, Exfoliation Glaucoma or Ocular Hypertension.

Sponsor: Larissa University Hospital

Conditions Glaucoma Ocular Hypertension
Interventions Bimatoprost and Bimatoprost/Timolol fixed combination.
Updated 5 times since 2017 Last updated: Nov 29, 2010 Started: Jul 31, 2009 Primary completion: Nov 30, 2010 Completion: Nov 30, 2010

Listed as NCT00941096, this PHASE4 trial focuses on Glaucoma and Ocular Hypertension and remains completed. Sponsored by Larissa University Hospital, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Larissa University Hospital
Data source: Larissa University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Larissa, Greece